A global generic pharmaceutical manufacturer with a smaller, but critically important, specialty branded pharmaceutical arm was seeking to better understand ...

A leading agile clinical trials technology and services provider engaged Clarkston to formulate an organizational design strategy to support their ...

In January of this year, billionaire investor Mark Cuban launched his latest venture, Cost Plus Drug Company. In partnership with ...

The global market for biosimilars is estimated to reach $15 billion by 2020 or 2021. While in Europe biosimilars have ...

For industry veterans, the 2019 generics industry trends reflect many of the dynamics, challenges, and opportunities that have faced the ...

Robotic process automation (RPA) is the use of artificial intelligence (AI) technology to automate routine, rules-based processes using complex “if, ...

For the seventh year in a row, Clarkston Consulting attended the Association for Accessible Medicines (AAM) Annual Meeting.  Many thanks ...

Since quality management’s inception at the turn of the 20th century, life sciences business leaders have predominantly viewed the field ...

In 2008, the European Medicines Agency began discussing serialisation requirements for pharmaceutical manufacturers—if you’re unfamiliar with serialisation this video is ...

Just like the design-thinking revolution in software, we are in the midst of a patient-centered care revolution in healthcare. For ...

Selecting the best Laboratory Information Management System (LIMS) for your business may depend upon complex business requirements but the vendor ...

While we’re heads down implementing serialization and traceability software or operationalizing new processes, we’re often asked a relatively simple question ...